Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Clinical trial NCT05631886 · RECRUITING

Trial details

NCT number: NCT05631886
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Lymphoma EphA2 Overexpression TP53 R273H TP53 R175H TP53 R248Q TP53 R249S

Start date: 2023-07-04
Primary completion: 2025-12-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.